Skip To Main Content
Clifton E Barry on Muck Rack

Clifton E Barry

As seen in: Nature, Wiley Online Library, MDPI, American Society for Microbiology (ASM)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Clifton E

Contact Clifton E, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A systematic efficacy analysis of tuberculosis treatment with BPaL‐containing regimens using a multiscale modeling approach

|
By Maral Budak, Clifton E Barry, Pariksheet Nanda, Danielle M. Weiner
| Wiley Online Library Verified
WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Tuberculosis (TB) kills 1.5 million people every year. To reduce the deaths caused by TB, many promising antibiotics, including the bedaquiline, pretomanid, and linezolid (BPaL) regimen, have been discovered that would potentially outperform the current standard treatment. Because combination treatment is necessary for TB, finding the best combination is an expensive process as a result of the high number of possible combinations.
Open in Who Shared Issue with article?

The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles

|
By Helena I. Boshoff, Neha Malhotra, Clifton E Barry, Sangmi Oh
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

The Tuberculosis Drug Accelerator at year 10: what have we learned?

|
By Bree B. Aldridge, David Barros-Aguirre, Clifton E Barry, Robert Bates
| Nature Verified
The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among competing labs and institutions, has reached a 10-year landmark. We review the consortium’s achievements, advantages and limitations and advocate for the application of similar models to other diseases.
Open in Who Shared Issue with article?
See all 5 articles